News
Patients express mixed feelings about AI in healthcare, favoring its use for documentation and administrative tasks while ...
Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback